SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-052967
Filing Date
2008-09-15
Accepted
2008-09-15 18:32:02
Documents
1
Period of Report
2008-09-11

Document Format Files

Seq Description Document Type Size
1 v126454_ex.html 4  
1 v126454_ex.xml 4 8960
  Complete submission text file 0001144204-08-052967.txt   10989
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VYTERIS, INC. 13-01 POLLITT DRIVE FAIR LAWN NJ 07410
Business Address 201-703-2299
McGuinness Michael (Reporting) CIK: 0001304506 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 081072684